IMRX
#3237
Immuneering Corporation - Class A Common Stock
5.0 3 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.45%
Variación mensual
+16.98%
Variación en los últimos 6 meses
+3.71%
Cambio anual
-10.50%
Cierres anteriores
5.2 1
Open
5.1 8
Mínimo
5.0 3
Máximo
5.1 8
Volumen
184
Financials
- Market Capitalization 325.43 M
- Employee 57
- Founded 2008
- CEO N/A
- Website www.immuneering.com
- Headquarter Delaware, United States
- FIGI BBG009QXJQS1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.18
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3220 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.41 USD | -2.43% | +0.42% | +4.33% | +30.27% | 336.28 M USD | ||
| 3233 |  ABEO Abeona Therapeutics Inc. - Common Stock | 5.88 USD | -2.65% | -3.61% | -3.13% | -15.15% | 336.24 M USD | ||
| 3265 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.23 USD | -3.86% | -2.61% | +1.95% | -5.42% | 316.22 M USD | ||
| 3290 |  IRD Opus Genetics, Inc. - Common Stock | 3.75 USD | -2.60% | -12.18% | +8.70% | +0.81% | 311.98 M USD |